✦ LIBER ✦

Acute myocardial infarction in pediatric systemic lupus erythematosus

✍ Scribed by Deborah M. Friedman; Herbert M. Lazarus; Arthur H. Flerman

Book ID: 117162315
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 393 KB
Volume: 117
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(05)80543-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myocardial infarction in systemic lupus

Myocardial infarction in systemic lupus erythematosus and “lupus-like” disease

✍ Ronald A. Asherson; Nigel Harris; Azzudin Gharavi; Graham R. V. Hughes 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 2 views

Infected acute myocardial infarct with r

Infected acute myocardial infarct with rupture in systemic lupus erythematosus

✍ Michael J. Cunningham; Paul L. Rothenberg; Sam Schatten; Peter H. Schur; Frederi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Acute Myocardial Infarction as the Prese

Acute Myocardial Infarction as the Presenting Symptom of Systemic Lupus Erythematosus

✍ Robin Doyle; James C. Perry; Joseph Brennan; John Fahey 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 201 KB

Thrombolytic therapy for a patient with

Thrombolytic therapy for a patient with systemic lupus erythematosus and acute myocardial infarction

✍ Juan C. García-Rubira; Juan T. García-Martinez; JoséM. Cruz 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Pediatric Systemic Lupus Erythematosus:

Pediatric Systemic Lupus Erythematosus: Characterization

✍ CHACONDEPETROLAJR, M; QUINTEROII, V; FLORES, M; TORRES, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Dyslipoproteinemia in pediatric systemic

Dyslipoproteinemia in pediatric systemic lupus erythematosus

✍ Norman T. Ilowite; Paul Samuel; Ellen Ginzler; Marc S. Jacobson 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Patients with systemic lupus erythematosus are at increased risk for premature atherosclerosis. We examined one possible etiologic factor, dyslipoproteinemia, both before and after corticosteroid therapy. We identified 2 distinct patterns of dyslipoproteinemia. One is attributable to active disease;